StockWatch
·
 Medicinal Chemicals and Botanical Products
DelistingJul 31, 2026, 04:37 PM

Upexi Receives Nasdaq Delisting Notice for Bid Price Non-Compliance

AI Summary

Upexi, Inc. received a notification from Nasdaq indicating non-compliance with the minimum bid price requirement of $1.00 per share. This was due to its common stock closing below $1.00 for 30 consecutive business days from June 16 to July 29, 2026. The company has an initial compliance period of 180 calendar days, until January 26, 2027, to regain compliance. Upexi intends to monitor its stock price and evaluate alternatives, including a reverse stock split, to meet the Nasdaq listing standard.

Key Highlights

  • Upexi received a Nasdaq notification for non-compliance with the $1.00 minimum bid price rule.
  • The company's common stock closed below $1.00 for 30 consecutive business days.
  • Upexi has an initial compliance period of 180 calendar days, until January 26, 2027.
  • To regain compliance, the stock must close at $1.00 or more for at least ten consecutive business days.
  • The company will monitor its stock and may consider a reverse stock split to regain compliance.